Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
11.11.19 | Idorsia Pharmaceuticals Ltd: Encouraging Phase 2 data on cenerimod - Idorsia's S1P1 receptor modulator currently investigated for SLE - presented at ACR 2019 | 535 | GlobeNewswire (Deutschland) | A Phase 2 safety study showed that cenerimod reduced circulating lymphocytes in a dose-dependent manner and was safe and well tolerated at doses up to 4 mg in patients with systemic lupus erythematosus... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 1.979 |
NEL | 1.870 |
SIEMENS ENERGY | 1.648 |
TUI | 1.284 |
MERCEDES-BENZ | 1.282 |
BAYER | 1.242 |
PALANTIR TECHNOLOGIES | 1.191 |
NVIDIA | 927 |
ALLIANZ | 920 |
DEUTSCHE BANK | 919 |
DEUTSCHE LUFTHANSA | 882 |
BYD | 844 |
PLUG POWER | 811 |
BORUSSIA DORTMUND | 777 |
INFINEON | 742 |
PUMA | 740 |
VARTA | 732 |
SMA SOLAR | 687 |
FRESENIUS | 636 |
RWE | 636 |
VOLKSWAGEN | 629 |
TESLA | 625 |
RHEINMETALL | 614 |
AIXTRON SE | 611 |
SUPER MICRO COMPUTER | 594 |